TrialCancer research communications2025

Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer.

Rona Yaeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.